234 related articles for article (PubMed ID: 25432020)
1. Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?
Jiang JH; Liu C; Cheng H; Lu Y; Qin Y; Xu YF; Xu J; Long J; Liu L; Ni QX; Yu XJ
Biochim Biophys Acta; 2015 Jan; 1855(1):43-9. PubMed ID: 25432020
[TBL] [Abstract][Full Text] [Related]
2. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
[TBL] [Abstract][Full Text] [Related]
3. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer.
Yamada S; Fuchs BC; Fujii T; Shimoyama Y; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y; Nakao A
Surgery; 2013 Nov; 154(5):946-54. PubMed ID: 24075276
[TBL] [Abstract][Full Text] [Related]
5. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
Wang S; Huang S; Sun YL
Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
[TBL] [Abstract][Full Text] [Related]
8. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer metastasis: are we being pre-EMTed?
Das S; Batra SK
Curr Pharm Des; 2015; 21(10):1249-55. PubMed ID: 25506899
[TBL] [Abstract][Full Text] [Related]
10. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
[TBL] [Abstract][Full Text] [Related]
13. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
14. The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer.
Kuwada K; Kagawa S; Yoshida R; Sakamoto S; Ito A; Watanabe M; Ieda T; Kuroda S; Kikuchi S; Tazawa H; Fujiwara T
J Exp Clin Cancer Res; 2018 Dec; 37(1):307. PubMed ID: 30537992
[TBL] [Abstract][Full Text] [Related]
15. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway.
Deng S; Zhu S; Wang B; Li X; Liu Y; Qin Q; Gong Q; Niu Y; Xiang C; Chen J; Yan J; Deng S; Yin T; Yang M; Wu H; Wang C; Zhao G
Cancer Lett; 2014 Dec; 355(2):184-91. PubMed ID: 25172416
[TBL] [Abstract][Full Text] [Related]
16. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
Liu H; Wang H; Liu X; Yu T
Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia.
Zhu H; Wang D; Zhang L; Xie X; Wu Y; Liu Y; Shao G; Su Z
Oncol Rep; 2014 Sep; 32(3):935-42. PubMed ID: 24994549
[TBL] [Abstract][Full Text] [Related]
18. Cooperative signaling between oncostatin M, hepatocyte growth factor and transforming growth factor-β enhances epithelial to mesenchymal transition in lung and pancreatic tumor models.
Argast GM; Mercado P; Mulford IJ; O'Connor M; Keane DM; Shaaban S; Epstein DM; Pachter JA; Kan JL
Cells Tissues Organs; 2011; 193(1-2):114-32. PubMed ID: 21041998
[TBL] [Abstract][Full Text] [Related]
19. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer.
Garg M
Cancer Metastasis Rev; 2015 Dec; 34(4):691-701. PubMed ID: 26328525
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
